E. Hoffman, R. Brown, and L. Kunkel, Dystrophin: The protein product of the duchenne muscular dystrophy locus, Cell, vol.51, issue.6, pp.919-928, 1987.
DOI : 10.1016/0092-8674(87)90579-4

M. Koenig, E. Hoffman, C. Bertelson, A. Monaco, C. Feener et al., Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals, Cell, vol.50, issue.3, pp.509-517, 1987.
DOI : 10.1016/0092-8674(87)90504-6

R. Roberts and M. Bobrow, Dystrophins in vertebrates and invertebrates, Human Molecular Genetics, vol.7, issue.4, pp.589-595, 1998.
DOI : 10.1093/hmg/7.4.589

L. Segalat, Dystrophin and functionally related proteins in the nematode Caenorhabditis elegans, Neuromuscular Disorders, vol.12, issue.1, pp.105-109, 2002.
DOI : 10.1016/S0960-8966(02)00090-1

M. Koenig, A. Monaco, and L. Kunkel, The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein, Cell, vol.53, issue.2, pp.219-226, 1988.
DOI : 10.1016/0092-8674(88)90383-2

S. Winder, T. Gibson, K. , and J. , Dystrophin and utrophin: the missing links! FeBS lett, pp.27-33, 1995.

L. Rumeur, E. Winder, S. Hubert, and J. , Dystrophin: More than just the sum of its parts, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1804, issue.9, pp.1713-1722, 2010.
DOI : 10.1016/j.bbapap.2010.05.001

URL : https://hal.archives-ouvertes.fr/hal-00592430

D. Blake, A. Weir, S. Newey, and K. Davies, Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle, Physiological Reviews, vol.82, issue.2, pp.291-329, 2002.
DOI : 10.1152/physrev.00028.2001

K. Campbell and S. Kahl, Association of dystrophin and an integral membrane glycoprotein, Nature, vol.338, issue.6212, pp.259-262, 1989.
DOI : 10.1038/338259a0

J. Chamberlain, K. Corrado, J. Rafael, G. Cox, M. Hausser et al., Interactions between dystrophin and the sarcolemma membrane, Soc Gen Physiol Ser, vol.52, pp.19-29, 1997.

B. Petrof, J. Shrager, H. Stedmann, A. Kelly, and H. Sweeney, Dystrophin protects the sarcolemma from stresses developed during muscle contraction., Proceedings of the National Academy of Sciences, vol.90, issue.8, pp.3710-3714, 1993.
DOI : 10.1073/pnas.90.8.3710

N. Deconinck and D. B. , Pathophysiology of Duchenne Muscular Dystrophy: Current Hypotheses, Pediatric Neurology, vol.36, issue.1, pp.1-7, 2007.
DOI : 10.1016/j.pediatrneurol.2006.09.016

C. Batchelor and S. Winder, Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy, Trends in Cell Biology, vol.16, issue.4, pp.198-205, 2006.
DOI : 10.1016/j.tcb.2006.02.001

I. Desguerre, C. Christov, M. Mayer, R. Zeller, H. Becane et al., Clinical Heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of Sub-Phenotypes and Predictive Criteria by Long-Term Follow-Up, PLoS ONE, vol.50, issue.2, p.4347, 2009.
DOI : 10.1371/journal.pone.0004347.t005

URL : https://hal.archives-ouvertes.fr/inserm-00447998

M. Koenig, A. Beggs, M. Moyer, S. Scherpf, K. Heindrich et al., The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion, Am J Hum Genet, vol.45, pp.498-506, 1989.

F. Magri, A. Govoni, D. Angelo, M. , D. Bo et al., Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up, Journal of Neurology, vol.4, issue.9, pp.1610-1623, 2011.
DOI : 10.1007/s00415-011-5979-z

A. Beggs, E. Hoffman, J. Snyder, K. Arahata, L. Specht et al., Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies, Am J Hum Genet, vol.49, pp.54-67, 1991.

K. Bushby, D. Gardner-medwin, L. Nicholson, M. Johnson, I. Haggerty et al., The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy, Journal of Neurology, vol.39, issue.2, pp.105-112, 1993.
DOI : 10.1007/BF00858726

G. Comi, A. Prelle, N. Bresolin, M. Moggio, A. Bardoni et al., Clinical variability in Becker muscular dystrophy Genetic, biochemical and immunohistochemical correlates, Brain, vol.117, issue.1, pp.1171-1185, 1994.
DOI : 10.1093/brain/117.1.1-a

V. Nigro, G. Nigro, M. Esposito, L. Comi, A. Molinari et al., Novel small mutations along the DMD/BMD gene associated with different phenotypes, Human Molecular Genetics, vol.3, issue.10, pp.1907-1908, 1994.
DOI : 10.1093/hmg/3.10.1907

L. Morandi, M. Mora, V. Confalonieri, R. Barresi, D. Blasi et al., Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype, Journal of the Neurological Sciences, vol.132, issue.2, pp.146-155, 1995.
DOI : 10.1016/0022-510X(95)00147-T

C. Beroud, S. Tuffery-giraud, M. Matsuo, D. Hamroun, V. Humbertclaude et al., Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy, Human Mutation, vol.18, issue.Web Server issu, pp.196-202, 2007.
DOI : 10.1002/humu.20428

URL : https://hal.archives-ouvertes.fr/inserm-00381940

R. Kaspar, H. Allen, W. Ray, C. Alvarez, J. Kissel et al., Analysis of Dystrophin Deletion Mutations Predicts Age of Cardiomyopathy Onset in Becker Muscular Dystrophy, Circulation: Cardiovascular Genetics, vol.2, issue.6, pp.544-551, 2009.
DOI : 10.1161/CIRCGENETICS.109.867242

C. Cunniff, J. Andrews, F. Meaney, K. Mathews, D. Matthews et al., Mutation Analysis in a Population-Based Cohort of Boys With Duchenne or Becker Muscular Dystrophy, Journal of Child Neurology, vol.14, issue.4, pp.425-430, 2009.
DOI : 10.1177/0883073808324770

A. Monaco, C. Bertelson, S. Liechti-gallati, H. Moser, and L. Kunkel, An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus, Genomics, vol.2, issue.1, pp.90-95, 1988.
DOI : 10.1016/0888-7543(88)90113-9

A. Aartsma-rus, J. Van-deutekom, I. Fokkema, G. Van-ommen, D. Dunnen et al., Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule, Muscle & Nerve, vol.56, issue.2, pp.135-144, 2006.
DOI : 10.1002/mus.20586

A. Winnard, C. Klein, D. Coovert, T. Prior, A. Papp et al., Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy, Human Molecular Genetics, vol.2, issue.6, pp.737-744, 1993.
DOI : 10.1093/hmg/2.6.737

N. Hattori, M. Kaido, T. Nishigaki, K. Inui, H. Fujimura et al., Undetectable dystrophin can still result in a relatively benign phenotype of dystrophinopathy, Neuromuscular Disorders, vol.9, issue.4, pp.220-226, 1999.
DOI : 10.1016/S0960-8966(99)00005-X

S. Tuffery-giraud, C. Saquet, D. Thorel, A. Disset, F. Rivier et al., Mutation spectrum leading to an attenuated phenotype in dystrophinopathies, European Journal of Human Genetics, vol.57, issue.12, pp.1254-1260, 2005.
DOI : 10.1126/science.1104297

F. Gualandi, M. Neri, M. Bovolenta, E. Martoni, P. Rimessi et al., Transcriptional behavior of DMD gene duplications in DMD/BMD males, Human Mutation, vol.30, issue.2, pp.310-319, 2009.
DOI : 10.1002/humu.20881

K. Anthony, S. Cirak, S. Torelli, G. Tasca, L. Feng et al., Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials, Brain, vol.134, issue.12, pp.3544-3556, 2011.
DOI : 10.1093/brain/awr291

J. Van-deutekom, A. Janson, I. Ginjaar, W. Frankhuizen, A. Aartsma-rus et al., Local Dystrophin Restoration with Antisense Oligonucleotide PRO051, New England Journal of Medicine, vol.357, issue.26, pp.2677-2686, 2007.
DOI : 10.1056/NEJMoa073108

M. Kinali, V. Arechavala-gomeza, L. Feng, S. Cirak, D. Hunt et al., Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study, The Lancet Neurology, vol.8, issue.10, pp.918-928, 2009.
DOI : 10.1016/S1474-4422(09)70211-X

S. Cirak, V. Arechavala-gomeza, M. Guglieri, L. Feng, S. Torelli et al., Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study, The Lancet, vol.378, issue.9791, pp.595-605, 2011.
DOI : 10.1016/S0140-6736(11)60756-3

N. Goemans, M. Tulinius, J. Van-den-akker, B. Burm, P. Ekhart et al., Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy, New England Journal of Medicine, vol.364, issue.16, pp.1513-1522, 2011.
DOI : 10.1056/NEJMoa1011367

S. White and J. Den-dunnen, Copy number variation in the genome; the human <i>DMD</i> gene as an example, Cytogenetic and Genome Research, vol.115, issue.3-4, pp.240-246, 2006.
DOI : 10.1159/000095920

S. Tuffery-giraud, C. Beroud, F. Leturcq, R. Yaou, D. Hamroun et al., Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase, Human Mutation, vol.23, issue.6, pp.934-945, 2009.
DOI : 10.1002/humu.20976

K. Campbell, Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage, Cell, vol.80, issue.5, pp.675-679, 1995.
DOI : 10.1016/0092-8674(95)90344-5

J. Chelly, G. Hamard, A. Koulakoff, J. Kaplan, A. Kahn et al., Dystrophin gene transcribed from different promoters in neuronal and glial cells, Nature, vol.344, issue.6261, pp.64-65, 1990.
DOI : 10.1038/344064a0

D. Souza, V. Nguyen, T. Morris, G. Karges, W. Pillers et al., A novel dystrophin isoform is required for normal retinal electrophysiology, Human Molecular Genetics, vol.4, issue.5, pp.837-842, 1995.
DOI : 10.1093/hmg/4.5.837

H. Lidov, S. Selig, and L. Kunkel, Dp140: a novel 140 kDa CNS transcript from the dystrophin locus, Human Molecular Genetics, vol.4, issue.3, pp.329-335
DOI : 10.1093/hmg/4.3.329

T. Byers, H. Lidov, and L. Kunkel, An alternative dystrophin transcript specific to peripheral nerve, Nature Genetics, vol.239, issue.1, pp.77-81
DOI : 10.1083/jcb.116.6.1369

J. Hugnot, H. Gilgenkrantz, N. Vincent, P. Chafey, G. Morris et al., Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues., Proceedings of the National Academy of Sciences, vol.89, issue.16, pp.7506-7510
DOI : 10.1073/pnas.89.16.7506

F. Norwood, A. Sutherland-smith, N. Keep, K. , and J. , The structure of the N-terminal actin-binding domain of human dystrophin and how mutations in this domain may cause Duchenne or Becker muscular dystrophy, Structure, vol.8, issue.5, pp.481-491, 2000.
DOI : 10.1016/S0969-2126(00)00132-5

X. Huang, F. Poy, R. Zhang, A. Joachimiak, M. Sudol et al., Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan, Nature Structural Biology, vol.7, issue.8, pp.634-638, 2000.
DOI : 10.1038/77923

B. Legrand, E. Giudice, A. Nicolas, O. Delalande, and E. Lerumeur, Computational Study of the Human Dystrophin Repeats: Interaction Properties and Molecular Dynamics, PLoS ONE, vol.40, issue.8, p.23819, 2011.
DOI : 10.1371/journal.pone.0023819.s010

URL : https://hal.archives-ouvertes.fr/inserm-00689190

A. Roy, A. Kucukural, and Y. Zhang, I-TASSER: a unified platform for automated protein structure and function prediction, Nature Protocols, vol.59, issue.4, pp.725-738, 2010.
DOI : 10.1038/nprot.2010.5

. Zhang, I-TASSER server for protein 3D structure prediction, BMC Bioinformatics, vol.9, issue.1, p.40, 2008.
DOI : 10.1186/1471-2105-9-40

M. Sippl, Recognition of errors in three-dimensional structures of proteins, Proteins: Structure, Function, and Genetics, vol.177, issue.4, pp.355-362, 1993.
DOI : 10.1002/prot.340170404

M. Wiederstein and M. Sippl, ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins, Nucleic Acids Research, vol.35, issue.Web Server, pp.407-410, 2007.
DOI : 10.1093/nar/gkm290

J. Bowie, R. Luthy, and D. Eisenberg, A method to identify protein sequences that fold into a known three-dimensional structure, Science, vol.253, issue.5016, pp.164-170, 1991.
DOI : 10.1126/science.1853201

R. Luthy, J. Bowie, and D. Eisenberg, Assessment of protein models with three-dimensional profiles, Nature, vol.356, issue.6364, pp.83-85, 1992.
DOI : 10.1038/356083a0

N. Menhart, Hybrid spectrin type repeats produced by exon-skipping in dystrophin, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1764, issue.6, pp.993-999, 2006.
DOI : 10.1016/j.bbapap.2006.03.017

T. Yokota, W. Duddy, and T. Patridge, Optimizing exon skipping therapies for DMD, Acta Myologica, vol.26, pp.179-184, 2007.

A. Lupas, Coiled coils: new structures and new functions, Trends in Biochemical Sciences, vol.21, issue.10, pp.375-382, 1996.
DOI : 10.1016/S0968-0004(96)10052-9

D. Parry, R. Fraser, M. John, and J. Squire, Fifty years of coiled-coils and ??-helical bundles: A close relationship between sequence and structure, Journal of Structural Biology, vol.163, issue.3, pp.258-269, 2008.
DOI : 10.1016/j.jsb.2008.01.016

I. Fokkema, J. Den-dunnen, and P. Taschner, LOVD: Easy creation of a locus-specific sequence variation database using an ???LSDB-in-a-box??? approach, Human Mutation, vol.21, issue.2, pp.63-68, 2005.
DOI : 10.1002/humu.20201

C. Beroud, D. Hamroun, G. Collod-beroud, C. Boileau, T. Soussi et al., UMD (Universal Mutation Database): 2005 update, ): 2005 update, pp.184-191, 2005.
DOI : 10.1002/humu.20210

URL : https://hal.archives-ouvertes.fr/inserm-00143605

K. Bushby, M. Thambyayah, and D. Gardner-medwin, Prevalence and incidence of Becker muscular dystrophy, The Lancet, vol.337, issue.8748, pp.1022-1024, 1991.
DOI : 10.1016/0140-6736(91)92671-N

S. Harper, M. Hauser, C. Dellorusso, D. Duan, R. Crawford et al., Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy, Nature Medicine, vol.8, issue.3, pp.253-261, 2002.
DOI : 10.1038/nm0302-253

S. Banuelos, M. Saraste, D. Carugo, and K. , Structural comparisons of calponin homology domains: implications for actin binding, Structure, vol.6, issue.11, pp.1419-1431, 1998.
DOI : 10.1016/S0969-2126(98)00141-5

A. Marchler-bauer, J. Anderson, F. Chitsaz, M. Derbyshire, C. Deweese-scott et al., CDD: specific functional annotation with the Conserved Domain Database, Nucleic Acids Research, vol.37, issue.Database, pp.37-205, 2009.
DOI : 10.1093/nar/gkn845

I. Letunic, T. Doerks, and P. Bork, SMART 6: recent updates and new developments, Nucleic Acids Research, vol.37, issue.Database, pp.229-232, 2009.
DOI : 10.1093/nar/gkn808

R. Finn, J. Mistry, J. Tate, P. Coggill, A. Heger et al., The Pfam protein families database, Nucleic Acids Res, pp.38-211, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01294685

M. Koenig and L. Kunkel, Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility, J Biol Chem, vol.265, issue.8, pp.4560-4566, 1990.

M. Ishikawa-sakurai, M. Yoshida, M. Imamura, K. Davies, and E. Ozawa, ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to ??-dystroglycan, Human Molecular Genetics, vol.13, issue.7, pp.693-702, 2004.
DOI : 10.1093/hmg/ddh087

K. Hnia, D. Zouiten, S. Cantel, D. Chazalette, G. Hugon et al., ZZ domain of dystrophin and utrophin: topology and mapping of a ??-dystroglycan interaction site, Biochemical Journal, vol.401, issue.3, pp.667-677, 2007.
DOI : 10.1042/BJ20061051

URL : https://hal.archives-ouvertes.fr/hal-00478628

M. Koenig, A. Monaco, and L. Kunkel, The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein, Cell, vol.53, issue.2, pp.219-228, 1988.
DOI : 10.1016/0092-8674(88)90383-2

M. Stone, O. Neill, A. Catino, D. Bloch, and R. , Specific Interaction of the Actin-binding Domain of Dystrophin with Intermediate Filaments Containing Keratin 19, Molecular Biology of the Cell, vol.16, issue.9, pp.4280-4293, 2005.
DOI : 10.1091/mbc.E05-02-0112

S. Legardinier, C. Raguenes-nicol, C. Tascon, C. Rocher, S. Hardy et al., Mapping of the Lipid-Binding and Stability Properties of the Central Rod Domain of Human Dystrophin, Journal of Molecular Biology, vol.389, issue.3, pp.546-558, 2009.
DOI : 10.1016/j.jmb.2009.04.025

URL : https://hal.archives-ouvertes.fr/inserm-00404317

K. Yamashita, A. Suzuki, Y. Satoh, M. Ide, Y. Amano et al., The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b, Biochemical and Biophysical Research Communications, vol.391, issue.1, pp.812-817, 2010.
DOI : 10.1016/j.bbrc.2009.11.144

K. Amann, B. Renley, and J. Ervasti, A Cluster of Basic Repeats in the Dystrophin Rod Domain Binds F-actin through an Electrostatic Interaction, Journal of Biological Chemistry, vol.273, issue.43, pp.27328419-28423, 1998.
DOI : 10.1074/jbc.273.43.28419

R. Bhosle, D. Michele, K. Campbell, Z. Li, and R. Robson, Interactions of intermediate filament protein synemin with dystrophin and utrophin, Biochemical and Biophysical Research Communications, vol.346, issue.3, pp.768-777, 2006.
DOI : 10.1016/j.bbrc.2006.05.192

Y. Lai, G. Thomas, Y. Yue, H. Yang, D. Li et al., Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy, Journal of Clinical Investigation, vol.119, issue.3
DOI : 10.1172/JCI36612DS1

G. Rezniczek, P. Konieczny, B. Nikolic, S. Reipert, D. Schneller et al., Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with betadystroglycan, J Cell Biol, issue.7, pp.176965-977, 2007.

S. Newey, M. Benson, C. Ponting, K. Davies, and D. Blake, Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex, Current Biology, vol.10, issue.20, pp.1295-1298, 2000.
DOI : 10.1016/S0960-9822(00)00760-0

H. Sadoulet-puccio, M. Rajala, and L. Kunkel, Dystrobrevin and dystrophin: An interaction through coiled-coil motifs, Proceedings of the National Academy of Sciences, vol.94, issue.23, pp.9412413-12418, 1997.
DOI : 10.1073/pnas.94.23.12413

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC24974

J. Reynolds, S. Mccalmon, J. Donaghey, and F. Naya, Deregulated Protein Kinase A Signaling and Myospryn Expression in Muscular Dystrophy, Journal of Biological Chemistry, vol.283, issue.13
DOI : 10.1074/jbc.C700221200

G. Ayalon, J. Davis, P. Scotland, and V. Bennett, An Ankyrin-Based Mechanism for Functional Organization of Dystrophin and Dystroglycan, Cell, vol.135, issue.7, pp.1189-1200, 2008.
DOI : 10.1016/j.cell.2008.10.018

K. Flanigan, D. Dunn, A. Von-niederhausern, P. Soltanzadeh, E. Gappmaier et al., Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort, Human Mutation, vol.23, issue.12, pp.301657-1666, 2009.
DOI : 10.1002/humu.21114

P. Taylor, S. Maroulis, G. Mullan, R. Pedersen, A. Baumli et al., Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy, Journal of Medical Genetics, vol.44, issue.6, pp.44368-372, 2007.
DOI : 10.1136/jmg.2006.047464

K. Dent, D. Dunn, A. Von-niederhausern, A. Aoyagi, L. Kerr et al., Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort, American Journal of Medical Genetics Part A, vol.23, issue.3, pp.295-298, 2005.
DOI : 10.1002/ajmg.a.30617

P. Taylor, G. Betts, S. Maroulis, C. Gilissen, R. Pedersen et al., Dystrophin Gene Mutation Location and the Risk of Cognitive Impairment in Duchenne Muscular Dystrophy, PLoS ONE, vol.5, issue.1, p.8803, 2009.
DOI : 10.1371/journal.pone.0008803.t002

Y. Nevo, F. Muntoni, C. Sewry, C. Legum, M. Kutai et al., Large inframe deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype, Isr Med Assoc J, vol.5, issue.2, pp.94-97, 2003.

A. Carsana, G. Frisso, M. Tremolaterra, R. Lanzillo, D. Vitale et al., Analysis of Dystrophin Gene Deletions Indicates that the Hinge III Region of the Protein Correlates with Disease Severity, Annals of Human Genetics, vol.10, issue.3, pp.69253-259, 2005.
DOI : 10.1046/J.1469-1809.2005.00160.x

H. Tsukamoto, K. Inui, H. Fukushima, T. Nishigaki, M. Taniike et al., Molecular study of duchenne and Becker muscular dystrophies in Japanese, Journal of Inherited Metabolic Disease, vol.17, issue.5, pp.819-824, 1991.
DOI : 10.1007/BF01799956

B. Janssen, C. Hartmann, V. Scholz, A. Jauch, and J. Zschocke, MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls, Neurogenetics, vol.11, issue.1, pp.29-35, 2005.
DOI : 10.1007/s10048-004-0204-1

C. Buzin, J. Feng, J. Yan, W. Scaringe, Q. Liu et al., Mutation rates in the dystrophin gene: A hotspot of mutation at a CpG dinucleotide, Human Mutation, vol.90, issue.Spec No, pp.177-188, 2005.
DOI : 10.1002/humu.20132

G. Ramelli, F. Joncourt, J. Luetschg, J. Weis, M. Tolnay et al., Becker muscular dystrophy with marked divergence between clinical and molecular genetic findings: case series, Swiss Med Wkly, vol.136, pp.11-12189, 2006.

L. Fajkusova, Z. Lukas, M. Tvrdikova, V. Kuhrova, J. Hajek et al., Novel dystrophin mutations revealed by analysis of dystrophin mRNA: alternative splicing suppresses the phenotypic effect of a nonsense mutation, Neuromuscular Disorders, vol.11, issue.2, pp.133-138, 2001.
DOI : 10.1016/S0960-8966(00)00169-3

T. Prior and S. Bridgeman, Experience and Strategy for the Molecular Testing of Duchenne Muscular Dystrophy, The Journal of Molecular Diagnostics, vol.7, issue.3, pp.317-326, 2005.
DOI : 10.1016/S1525-1578(10)60560-0